Read + Share
Amedeo Smart
Independent Medical Education
Koenig LM, Boehmer DFR, Metzger P, Schnurr M, et al. Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19. J Exp Med 2020;217.PMID: 32678432
Email
LinkedIn
Facebook
Twitter
Privacy Policy